Without social change or new therapies, alcohol-associated liver disease (ALD) and metabolic dysfunction–associated steatotic liver disease (MASLD; formerly called nonalcohol-related fatty liver disease) will likely
Proton pump inhibitor (PPI) use may be an important and preventable source of fatigue and reduced health-related quality of life (HRQoL) in people who received
Using a case-based approach, authors of a review article describe “synthesizing pharmacogenomics, therapeutic drug monitoring, pharmacokinetics, and pharmacodynamic principles” to address “drug–drug, drug–gene, and drug–drug-gene
Among 158 immunosuppressed solid-organ transplant recipients, oral nicotinamide therapy did not lower the numbers of keratinocyte cancers or actinic keratoses over a 1-year period. In
In kidney transplant recipients (KTR), the use of PPIs is independently associated with fatigue and lower health-related quality of life (HRQoL), researchers report. “PPI use
A study shows that the decline in estimated glomerular filtration rate (GFR) was not slowed over a 2-year period in adult kidney transplant recipients when
Recipients of solid organ transplants (SOTs) had the highest risk of breakthrough infection (BI) when they had poorer antibody response (AbR) to SARS-CoV-2 vaccination, had
Within 30 days of bilateral lung transplantation (LT), one-third of recipients had multidrug-resistant (MDR) and extended-spectrum β-lactamase (ESBL) gram-negative (GN) bacteria and 6-fold greater risk
